Summary:
UCLA researchers in the Department of Integrative Biology & Physiology have developed a novel small molecule-based approach for enhancing lipid accumulation and adipogenesis in edible adipose tissues for cultured meat production.
Background:
With the global population expanding rapidly, there is an urgent demand for sustainable protein sources that can mitigate severe environmental impacts. These impacts include high greenhouse gas emissions and heavy resource consumption, associated with conventional livestock farming. Cultured meat has emerged as a promising approach for building a more resilient food system; however, reproducing the sensory qualities of traditional meat remains a major barrier to widespread consumer adoption. Fat content plays a critical role in the tenderness, juiciness, flavor, and overall mouthfeel of meat, yet much of the cultured meat field has focused on scalable muscle tissue production while scalable adipose tissue production remains less developed. Current approaches rely on costly media additives, inefficient production methods, or growth scaffolds that complicate downstream processing and increase production costs. There remains an unmet need for cost-effective and scalable strategies that can enhance lipid accumulation and support the production of cultured adipose tissue.
Innovation:
UCLA researchers have developed a novel small molecule-based technology for enhancing adipogenesis and lipid accumulation in edible adipose tissues for cultured meat production. This technology uses identified nutrient additives to promote fat cell differentiation and lipid buildup, enabling more efficient production of engineered fat tissue. The inventors demonstrated that the naturally occurring compounds incorporated significantly increased adipogenesis, suggesting their efficacy as synergistic food additives for cultivated adipose tissue production. Importantly, transcriptomic and proteomic analyses show that the naturally occurring small molecules induce adipogenesis in murine and porcine cell systems through canonical adipogenic pathways with a narrower transcriptional footprint than the potent PPARγ agonist rosiglitazone. The approach is designed to support scalable biomanufacturing of adipose tissue while reducing reliance on inefficient or costly production steps. The technology may also be compatible with edible scaffold-based production systems, supporting more streamlined downstream processing. By enabling improved lipid accumulation at the cellular level, this innovation directly addresses the need for fat component of future food products – including both plant-based and cultivated meats – which is critical for the flavor, texture, mouthfeel, nutritional composition, and overall consumer appeal.
Potential Applications:
- Cultured adipose tissue production for cultivated meat products
- Cultivated adipose tissue as an ingredient for plant-based meat products
- Edible scaffold-compatible production of adipose microtissues for scalable meat biomanufacturing
- Development of premium cultured meat products with improved tenderness, juiciness, flavor, and mouthfeel
- Streamlined identification process of novel small molecules for cell future engineering applications
Advantages:
- Enhances lipid accumulation in adipocytes for more efficient cultured fat production
- Accelerates adipogenesis of edible adipose tissues for future food applications
- Compatible with scalable biomanufacturing workflows for engineered adipose tissue production
- Uses a food-oriented small molecule approach that may reduce reliance on costly or inefficient production methods
State of Development: The technology has been demonstrated at the proof-of-concept stage using a pre-adipocyte cell model, where increased lipid accumulation in murine, porcine, and ovine cells were observed following treatment with the selected small molecule enhancers. The researchers have evaluated the approach also in cell culture contexts that are relevant towards scaleup including edible microcarrier culture.
Related Publications: Manuscript submitted for publication June 2026.
Reference: UCLA Case No. 2024-125
Inventors: Amy Rowat; Robert Damoiseaux, Qingwen Xie